HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Eržen Selected Research

Fluvastatin

9/2018Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study.
3/2017Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
12/2015A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study.
9/2015Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination.
9/2013Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Eržen Research Topics

Disease

3Myocardial Infarction
09/2018 - 09/2013
2Peripheral Arterial Disease
01/2022 - 05/2014
2Hyperemia
10/2018 - 09/2018
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2015 - 09/2013
1Pathologic Constriction (Stenosis)
01/2022
1Type 2 Diabetes Mellitus (MODY)
03/2017
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Atherosclerosis
01/2014
1Inflammation (Inflammations)
01/2014
1Insulin Resistance
09/2013
1Obesity
09/2013

Drug/Important Bio-Agent (IBA)

5Valsartan (Vals)FDA Link
09/2018 - 09/2013
5FluvastatinFDA Link
09/2018 - 09/2013
2C-Reactive ProteinIBA
10/2018 - 01/2014
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2018 - 01/2014
2Plasminogen Activator Inhibitor 1IBA
01/2014 - 09/2013
1AntioxidantsIBA
10/2018
1Interleukin-6 (Interleukin 6)IBA
10/2018
1Sirtuin 1IBA
10/2018
1AntigensIBA
09/2013
1Plasminogen Activators (Plasminogen Activator)IBA
09/2013
1Plasminogen InactivatorsIBA
09/2013

Therapy/Procedure

5Therapeutics
09/2018 - 01/2014
1Stents
01/2022